FAM
CSTL icon

Fred Alger Management’s Castle Biosciences CSTL Stock Holding History

Fred Alger Management’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-51,883
Closed -$2.33M – 515
2022
Q1 		$2.33M Buy
+51,883
New +$2.14M 0.01% 332
2021
Q4 		– Sell
-80,293
Closed -$5.34M – 523
2021
Q3 		$5.34M Buy
+80,293
New +$5.65M 0.01% 284
2021
Q1 		– Sell
-21,839
Closed -$1.47M – 488
2020
Q4 		$1.47M Buy
21,839
+11,460
+110% +$621K ﹤0.01% 345
2020
Q3 		$534K Sell
10,379
-5,621
-35% -$250K ﹤0.01% 375
2020
Q2 		$603K Hold
16,000
– – ﹤0.01% 386
2020
Q1 		$477K Sell
16,000
-6,000
-27% -$181K ﹤0.01% 363
2019
Q4 		$756K Buy
22,000
+2,000
+10% +$48.9K ﹤0.01% 364
2019
Q3 		$362K Buy
+20,000
New +$443K ﹤0.01% 381

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Fred Alger Management's CSTL Position: Q2 2022 in Review

Fred Alger Management sold out of Castle Biosciences (CSTL) in Q2 2022, closing a stake of 51,883 shares — an estimated $2.33M sold.

Fred Alger Management first reported a position in CSTL in Q3 2019 and held it in 8 quarters. The position peaked at $5.34M in Q3 2021. 146 funds tracked by Wall St. Rank hold CSTL as of Q2 2022.

  • Fred Alger Management reported no remaining Castle Biosciences position as of Q2 2022 after selling out during the quarter.
  • Fred Alger Management sold 51,883 Castle Biosciences shares in Q2 2022, an estimated $2.33M.
  • Fred Alger Management first reported a position in Castle Biosciences in Q3 2019 and held it in 8 quarters.
  • Fred Alger Management's Castle Biosciences position peaked at $5.34M in Q3 2021.
  • 146 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2022.

Based on Fred Alger Management's 13F filing for Q2 2022, filed 15 Aug 2022.